Characterization of multidrug resistance-associated protein mRNAs expression profiles in Caco-2 and HT-1080 cell lines induced by methotrexate

Pharmazie

Volumn 63, Issue 12, 2008, Pages 883-889

  Ikeda, Kenji ^a   Myotoku, M ^a   Hirotani, Y ^a  

^a OSAKA OHTANI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; METHOTREXATE; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; MULTIDRUG RESISTANCE PROTEIN 4; MULTIDRUG RESISTANCE PROTEIN 5; MULTIDRUG RESISTANCE PROTEIN 6; MULTIDRUG RESISTANCE PROTEIN 7; MULTIDRUG RESISTANCE PROTEIN 8; UNCLASSIFIED DRUG; ABC TRANSPORTER; ABCB1 PROTEIN, HUMAN; ABCG2 PROTEIN, HUMAN; ANTINEOPLASTIC ANTIMETABOLITE; GLYCOPROTEIN P; TUMOR PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL STRAIN CACO 2; COMPARATIVE STUDY; CONTROLLED STUDY; FIBROSARCOMA; HUMAN; HUMAN CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RNA ANALYSIS; BIOSYNTHESIS; CELL PROLIFERATION; DRUG EFFECT; DRUG RESISTANCE; GENETICS; METABOLISM; MULTIDRUG RESISTANCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; TUMOR CELL LINE;

ANTIMETABOLITES, ANTINEOPLASTIC; ATP-BINDING CASSETTE TRANSPORTERS; CACO-2 CELLS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; METHOTREXATE; MYOCYTES, SMOOTH MUSCLE; NEOPLASM PROTEINS; P-GLYCOPROTEIN; P-GLYCOPROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 61449200375     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.8166     Document Type: Article

References (20)

1. Assaraf YG (2006) The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis. Drug Resist Updat 9: 227-246.
2. Assaraf YG (2007) Molecular basis of antifolate resistance. Cancer Metastasis Rev 26: 153-181.
3. Chabner BA, Allegra CJ, Curt GA, Clendeninn NJ, Baram J, Koizumi S, Drake JC, Jolivet J (1985) Polyglutamation of methotrexate. Is methotrexate a prodrug? J Clin Invest 76: 907-912.
4. Chen X, Baker SM, Chen G (2005) Methotrexate induction of human sulfotransferases in Hep G2 and Caco-2 cells. J Appl Toxicol 25: 354-360.
5. Chen ZS, Robey RW, Belinsky MG, Shchaveleva I, Ren XQ, Sugimoto Y, Ross DD, Bates SE, Kruh GD (2003) Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport. Cancer Res 63: 4048-4054.
6. Choudhuri S, Klaassen CD (2006) Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters. Int J Toxicol 25: 231-259.
7. Dixit SG, Zingarelli B, Buckley DJ, Buckley AR, Pauletti GM (2005) Nitric oxide mediates increased P-glycoprotein activity in interferon-{gamma}- stimulated human intestinal cells. Am J Physiol Gastrointest Liver Physiol 288: G533-G540.
8. Hooijberg JH, Broxterman HJ, Kool M, Assaraf YG, Peters GJ, Noordhuis P, Scheper RJ, Borst P, Pinedo HM, Jansen G (1999) Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2. Cancer Res 59: 2532-2535.
9. Horie T, Li T, Ito K, Sumi S, Fuwa T (2006) Aged garlic extract protects against methotrexate-induced apoptotic cell injury of IEC-6 cells. J Nutr 136: 861S-863S.
10. Ikeda K, Utoguchi N, Makimoto H, Mizuguchi H, Nakagawa S, Mayumi T (1999) Different reactions of aortic and venular endothelial cell monolayers to histamine on macromolecular permeability: role of cAMP, cytosolic Ca2+ and F-actin. Inflammation 23: 87-97.
11. König J, Hartel M, Nies AT, Martignoni ME, Guo J, Büchler MW, Friess H, Keppler D (2005) Expression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma. Int J Cancer 115: 359-367.
12. Lesuffleur T, Barbat A, Dussaulx E, Zweibaum A (1990) Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. Cancer Res 50: 6334-6343.
13. Li WW, Takahashi N, Jhanwar S, Cordon-Cardo C, Elisseyeff Y, Jimeno J, Faircloth G, Bertino JR (2001) Sensitivity of soft tissue sarcoma cell lines to chemotherapeutic agents: identification of ecteinascidin-743 as a potent cytotoxic agent. Clin Cancer Res 7: 2908-2911.
14. Prime-Chapman HM, Fearn RA, Cooper AE, Moore V, Hirst BH (2004) Differential multidrug resistance-associated protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cells. J Pharmacol Exp Ther 311: 476-484.
15. Schwarzenbach H (2002) A diagnostic tool for monitoring multidrug resistance expression in human tumor tissues. Anal Biochem 308: 26-33.
16. Srimatkandada S, Schweitzer BI, Moroson BA, Dube S, Bertino JR (1989) Amplification of a polymorphic dihydrofolate reductase gene expressing an enzyme with decreased binding to methotrexate in a human colon carcinoma cell line, HCT-8R4, resistant to this drug. J Biol Chem 264: 3524-3528.
17. Volk EL, Schneider E (2003) Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter. Cancer Res 63: 5538-5543.
18. Wielinga P, Hooijberg JH, Gunnarsdottir S, Kathmann I, Reid G, Zelcer N, van der Born K, de Haas M, van der Heijden I, Kaspers G, Wijnholds J, Jansen G, Peters G, Borst P (2005) The human multidrug resistance protein MRP5 transports folates and can mediate cellular resistance against antifolates. Cancer Res 65: 4425-4430.
19. Xia CQ, Liu N, Yang D, Miwa G, Gan LS (2005) Expression, localization, and functional characteristics of breast cancer resistance protein in Caco-2 cells. Drug Metab Dispos 33: 637-643.
20. Zhang CY, Feng YX, Yu Y, Sun WJ, Bai J, Chen F, Fu SB (2006) The molecular mechanism of resistance to methotrexate in mouse methotrexate- resistant cells by cancer drug resistance and metabolism SuperArray. Basic Clin Pharmacol Toxicol 99: 141-145.